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Case Study
Introduction
Brain cancer is a devastating and highly debilitating form of 
cancer. In 2014, there were an estimated 23 000 new cases 
of brain and nervous system cancers in the United States 
alone.1 This number is fairly low compared to the incidence 
of breast or prostate cancer but is particularly challenging 
because of the poor prognosis for brain tumors; approxi-
mate 5-year survival rates are less than 30%,2 and there is 
a mean survival time of approximately 15 months for 
glioblastoma, the most common malignant brain tumor.3 
Moreover, brain cancer is one of very few tumor sites that 
have not seen a decline in mortality over the past 20 years.4
The impact of brain cancer and its associated treatments 
often results in impaired physical capabilities, mild or major 
cognitive dysfunction, and compromised psychological 
well-being.5,6 Therefore, adjuvant and supportive care that 
facilitates an improved quality of life and reduces these 
adverse effects should be considered for brain cancer sur-
vivors (we use the term survivor in accordance with the 
definition by National Coalition for Cancer Survivorship as 
someone who has been diagnosed with cancer and is still 
alive, regardless of the stage of their disease or the treat-
ment that they are receiving).7 A large body of evidence has 
emerged to support the prescription of exercise as a thera-
peutic and supportive form of care for cancer survivors. 
Indeed, the American College of Sports Medicine (ACSM) 
and the American Cancer Society (ACS) are among the 
many international organizations that have specific exercise 
guidelines for cancer survivors.8,9 These guidelines were, 
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Abstract
Background. Malignant brain tumors are unpredictable and incurable, with 5-year survival rates less than 30%. The poor 
prognosis combined with intensive treatment necessitates the inclusion of complementary and supportive therapies that 
optimize quality of life and reduce treatment-related declines in health. Exercise therapy has been shown to be beneficial 
in other cancer populations, but no evidence is available for brain cancer survivors. Therefore, we report results from 2 
preliminary cases. Methods. Two female patients diagnosed with glioblastoma multiforme and oligodendroglioma participated 
in a structured and supervised 12-week exercise program. The program consisted of two 1-hour resistance and aerobic 
exercise sessions per week and additional self-managed aerobic sessions. Outcome measures of strength, cardiovascular 
fitness, and several psychological indicators (depression, anxiety, and quality of life) were recorded at baseline, after 6 weeks 
and at the conclusion of the intervention. Results. Exercise was well tolerated; both participants completed all 24 sessions 
and the home-based component with no adverse effects. Objective outcome measures displayed positive responses relating 
to reduced morbidity. Similar positive responses were found for psychological outcomes. Scores on the Hospital Anxiety 
and Depression Scale showed clinically meaningful improvements in depression and total distress. Conclusion. These findings 
provide initial evidence that, despite the difficulties associated with brain cancer treatment and survivorship, exercise may 
be safe and beneficial and should be considered in the overall management of patients with brain cancer.
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however, compiled from research outcomes comprising 
breast, prostate, colon, hematological, and gynecological 
cancers. Therefore, the potential beneficial impact of 
exercise for brain cancer survivors remains unknown. 
Nonetheless, previous research has pointed toward a rela-
tionship between exercise engagement and survival time 
in recurrent glioma patients.10 Additionally, Cormie et al11 
recently presented a theoretical perspective of the potential 
impacts of including exercise as a form of supportive care 
for neuro-oncology survivors.
Therefore, this report aims to contribute to empirical 
evidence by describing the outcomes of 2 distinct case 
studies of brain cancer survivors who undertook a 12-week 
structured and supervised exercise program by highlight-
ing clinically important outcomes, including the ability to 
tolerate and adhere to the exercise program.
Methods
Participants
Two case studies have been drawn from a larger feasibility 
trial that aimed to examine exercise for the management of 
depression in depressed cancer survivors.12 These were the 
only 2 brain cancer survivors within the trial who met 
inclusion criteria for participation: (1) able to understand 
written English; (2) able to walk 400 m unassisted; (3) family 
physician consent confirming no musculoskeletal, cardio-
vascular, or neurological limitations; and (4) elevated 
depressive symptoms at baseline. This case study exami-
nation is unique because the 2 participants were diagnosed 
with different brain tumors and were at various stages 
within their cancer care continuum. Participant A (58 years 
old, 163 cm, 66.4 kg, 62 months postdiagnosis) was first 
diagnosed with low-grade glioma in the right frontal lobe in 
2007, which was treated with surgical resection. She under-
went repeat resection in 2012 for recurrent disease followed 
by radiotherapy. Her disease at this time transformed to 
grade III anaplastic oligodendroglioma. On commence-
ment of the exercise program, her medications included 
thyroxine, lamotrigine, sertraline, calcium, and latanoprost. 
Participant A was 288 months postdiagnosis for clinical 
depression and had a history of pharmacotherapy and psy-
chotherapy, including current antidepressant medication. 
Participant B (61 years old, 164 cm, 59.4 kg, 5 months 
postdiagnosis) was diagnosed with right frontal lobe 
glioblastoma multiforme in December 2012. She received 
standard treatment consisting of surgical excision followed 
by concurrent radiotherapy with temozolomide chemo-
therapy. She developed progressive disease despite these 
treatments. She was receiving intravenous bevacizumab 
fortnightly when she entered the exercise trial. Her other 
medications included levetiracetam, dexamethasone, 
omeprazole, vitamin D, and temazepam. Participant B had 
not been clinically diagnosed with depression but presented 
with severe symptomatology according to the Hospital 
Anxiety and Depression Scale (HADS; see Table 1). Neither 
participant had any other diagnosed illness or chronic 
disease. Both were female, married, and educated to a 
bachelor’s degree level. Both participants were supportive 
of the research and provided written informed consent.
Exercise Intervention
A 12-week exercise intervention, performed twice weekly, 
was supervised by an accredited exercise physiologist. Each 
supervised exercise session consisted of 20 minutes of 
moderate to vigorous aerobic exercise (eg, treadmill, 
cycling ergometer, rowing ergometer) and 40 minutes of 
resistance training. The resistance training targeted all the 
major upper- and lower-body muscle groups, using the 
following 9 exercises: chest press, leg press, lateral pull-
down, knee extension, knee flexion, seated row, lateral 
shoulder raises, step up, and bicep curls. The load of external 
resistance was established in the first 2 weeks and subse-
quently increased to ensure that the participants always 
performed at a specified intensity. In the first 2 weeks, 
participants performed 2 sets of 12 repetitions (2 × 12), 
followed by 3 × 10 for 4 weeks, 3 × 8 for 3 weeks, and 
4 × 6 for the final 3 weeks. The 2 supervised exercise sessions 
were supplemented with additional home-based aerobic 
exercise. Participants were encouraged to accumulate a 
total of 150 minutes of aerobic exercise, not including their 
2 resistance training sessions, to meet recommended physical 
activity guidelines of 150 min/wk.8 A home-based activity 
log was provided at baseline and monitored regularly.
Outcome Measures
Objective physical and physiological measures, along 
with subjective patient-reported outcomes (PROs), were 
recorded at baseline, after 6 weeks, and again after comple-
tion of the 12-week program. All measures were collected 
in a single 90-minute session at the university health and 
wellness institute. All measures were taken in the same 
order at each testing session.
Physical and Physiological Measures
Aerobic adaptations. To examine cardiovascular adapta-
tions to exercise, oxygen consumption (VO2) and heart rate 
(HR) responses were measured during the first 2 stages of 
a modified Bruce Treadmill protocol.13 These stages cor-
respond to velocities of 2.7 and 4.0 km/h at gradients of 
10% and 12%, respectively. Oxygen uptake was measured 
through indirect calorimetry (Parvo Metabolic Measuring 
System, Sandy, UT). Additionally, the participants per-
formed a 400-m long corridor walk test, which can be used 
as a measure of physical function and act as a surrogate 
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measure of aerobic capacity.14,15 Performance was assessed 
by measuring the time taken to complete this task.
Muscle strength and body composition. Maximal concen-
tric muscle strength was assessed for the upper (chest press) 
and lower (leg press) body using the 1 repetition maximum 
(1-RM) method.16 Participants performed a graded warm-up 
consisting of one set of 6 repetitions at a light weight, fol-
lowed by a second set of 3 lifts at a heavier weight. Thereafter, 
single lift sets were performed until reaching the 1-RM; the 
weight that could be lifted only once with correct form and 
technique.14 All 1-RMs were determined within 5 attempts. 
Changes in total body lean muscle and fat mass composition 
and percentage body fat were assessed using dual energy X-ray 
absorptiometry (DXA, Hologic Discovery A, Waltham, MA).
Patient-Reported Outcomes. Several well-validated question-
naires examined psychosocial outcomes. Measures included 
quality of life, depression, anxiety, total distress, satisfaction 
with life, cancer-specific self-efficacy, and sleep quality.
Quality of life was recorded using the Short Form-36 v2 
(SF-36),17 which comprises 8 subscales of the SF-36, and 
the 2 composite scores of physical (PHC) and mental 
(MHC) health are reported. These composite scores are pre-
sented for comparison to the normalized mean T score of 50 
and a standard deviation of 10.18 Depression (HADS-D), 
anxiety (HADS-A), and total distress were all recorded using 
the HADS.19 Although the HADS is a single 14-question 
scale, the use of the individual subscales to assess anxiety and 
depression independently is well supported.20 Satisfaction 
with life was measured using the brief 5 questions of the 
Table 1. Outcome Measures Reported for Each Assessment Point for Both Participants.
Participant A Participant B
 Baseline 6 Weeks 12 Weeks Baseline 6 Weeks 12 Weeks
VO2 (ml/kg/min)
 Rest 3.45 5.36 4.99 5.47 4.78 5.45
 Stage 1 14.51 15.56 13.75 15.13 15.34 15.65
 Stage 2 22.32 21.35 19.27 20.79 18.91 20.32
Heart rate (bpm)
 Rest 79 74 72 93 81 74
 Stage 1 101 97 93 103 96 86
 Stage 2 119 115 111 110 109 103
Functional fitness
 400 m walk (s) 258.6 251.8 248.7 250.5 241.6 231.3
Strength (kg)
 Chest press 1-RM 17.5 20.0 20.0 12.5 17.5 20.0
 Leg press 1-RM 76.5 76.5 90.0 49.5 58.5 72.0
Body composition
 Lean mass (kg) 39.1 38.1 36.9 36.5 36.5 37.9
 Fat mass (kg) 25.3 25.7 26.1 21.4 19.8 18.7
 Percentage body fat (%) 38.0 39.0 40.1 35.9 34.1 32.0
MHC: SF-36 34.70 28.91 33.68 27.39 28.64 54.77
PHC: SF-36 47.52 46.86 50.65 46.24 41.51 38.36
HADS 23 18 14 24 27 13
 HADS-D 10 8 6 12 15 6
 HADS-A 13 10 8 12 12 7
SWLS 11 19 29 7 5 17
CASES 115 119 149 110 111 156
PSQI 16 17 12 12 14 15
Exercise engagement
 Total (min/wk) 240 405 220 180 250 450
Exercise intensity (min/wk)
 Mild 0 105 100 60 90 315
 Moderate 60 60 0 120 160 135
 Strenuous 180 240 120 0 0 0
Abbreviations: VO2, oxygen consumption; bpm, beats per minute; 1-RM, 1 repetition maximum; MHC, mental health composite; PHC, physical health 
composite; SF-36, Short Form 36; HADS, Hospital Anxiety and Depression Scale; HADS-D, HADS depression subscale; HADS-A, HADS anxiety 
subscale; SWLS, Satisfaction with Life Scale; CASES, Cancer Self-Efficacy Scale; PSQI, Pittsburgh Sleep Quality Index.
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Satisfaction With Life Scale (SWLS).21 The ability to 
manage living with cancer was measured using the Lewis 
Cancer Self-Efficacy Scale (CASES).22,23 This question-
naire comprises 17 items (eg, “I am able to manage what is 
being asked of me despite the cancer”) that are scored on an 
11-point Likert scale ranging from 0 (not at all confident) to 
10 (very confident). In accordance with the authors’ instruc-
tions, participants were asked to rate their level of confi-
dence to manage or cope with cancer-related problems for 
that particular day. Higher scores represent increased self-
efficacy. Finally, the Pittsburgh Sleep Quality Index (PSQI), 
which measures sleep outcomes over the previous 1-month 
period was used to assess changes in sleep quality.24
Physical Activity and Exercise Adherence. A modified version of 
the Godin Leisure Time Exercise Questionnaire was used to 
determine physical activity levels.25 This questionnaire asks 
participants to record how often they performed exercise in 
the previous week and to categorize the intensity of each 
session as mild, moderate, or strenuous. Two modifications 
were made to the original questionnaire to accurately quan-
tify exercise activity. First, the minimum time requirement 
was lowered from 15 to 10 minutes, which is more in line 
with current exercise guidelines suggested by the ACSM.26 
Second, the average duration of each session was reported. 
These changes allowed for the determination of whether 
an individual was meeting international physical activity 
guidelines for cancer survivors.8 Exercise adherence was 
measured by comparing the total number of sessions 
attended with the number scheduled over the 12 weeks.
Results
Objective assessments showed improvements in physical 
health indicators in both participants; however, the patterns 
of improvement were not always similar (Table 1). Both 
participants showed an improvement in cardiovascular effi-
ciency demonstrated by the comparatively lower HR at each 
stage across time and a reduction in time to complete the 
400-m walk test. However, they displayed variable oxygen 
consumption responses. Maximal strength, summed as the 
total of the upper- and lower-body exercise tests, increased 
by 17% and 48%, regardless of the variable body composi-
tion responses. Subjective PROs also varied between the 2 
participants. However, over the entire 12-week program, 
there was a consistent improvement for all mental health 
outcomes. Both participants showed clinically meaningful 
reductions in depression, anxiety, and total distress, reducing 
symptomatology below cutoff scores used to represent 
clinical caseness.27 This change occurred with concomitant 
increases in satisfaction with life (SWLS) and cancer coping 
self-efficacy (CASES). Little change was noted for sleep 
quality, and both participants consistently reported scores 
above 5, which is used to indicate sleep disturbance.24
It is important to note that no adverse events occurred 
throughout the intervention. Both participants demonstrated 
100% adherence, attending all 24 scheduled sessions. 
Furthermore, participant A completed an additional 35 
home-based aerobic sessions, 16 in the first 6 weeks and 19 
in the following 6 weeks. Participant B completed an addi-
tional 44 sessions over the 12 weeks, 22 in each 6-week 
period. Both participants were highly active at baseline, but 
still managed to increase their exercise engagement for the 
first 6 weeks; thereafter, participant A declined below base-
line levels, whereas participant B continued to increase, 
more than doubling her total physical activity minutes 
compared with baseline levels.
Discussion
The aim of this report was to examine whether a 12-week 
structured and supervised exercise program was beneficial 
and of clinical benefit within a supportive care framework 
for cancer survivors with brain tumors. Two unique partici-
pants, who presented with common tumors and at vastly 
different stages of prognoses, participated in a similar exer-
cise program, individualized only by intensity but not by 
exercise selection. The results achieved by both participants 
present initial evidence indicating that physical and mental 
health is enhanced after commencing a supervised, struc-
tured, and professionally led exercise program.
In line with expectations from a structured and super-
vised exercise program, both participants increased muscle 
strength and cardiovascular fitness. These findings are clin-
ically important for several reasons. First, both participants 
were already active and meeting physical activity recommen-
dations set by the ASCM for cancer survivors.8 Therefore, 
based on the dose-response theory, the 2 participants had a 
reduced capacity for physical improvement compared with 
inactive survivors,26,28 which may account for the relatively 
low percentage increase in maximal strength shown by 
participant A. Second, the medications prescribed for the 2 
participants as well as the ongoing chemotherapy (bevaci-
zumab) for participant B are known to have deleterious 
effects on physical function and fitness. It is well docu-
mented that patients undergoing chemotherapy and radi-
ation therapy experience treatment-related symptoms (eg, 
fatigue, reduced strength, and reduced fitness),29-31 and 
when used in combination, these effects are magnified and 
can be long lasting.32 Both these participants had previous 
exposure to cranial radiotherapy and participant B also had 
multiple sessions of chemotherapy. Additionally, both par-
ticipants were taking prescribed antiepileptic medications 
(lamotrigine and levetiracetam), which also commonly pres-
ent lead to symptoms of headaches, nausea, and fatigue.33 
These medications and adverse effects have a multiplicative 
effect in reducing the capacity for physical activity. 
Therefore, the improvements for these 2 participants likely 
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occurred when decrements in cardiorespiratory fitness 
and muscle strength may otherwise have been expected. 
Notably, the continued engagement in moderate to vigorous 
exercise may have the potential not only to decrease 
morbidity, but also decrease mortality. Previous research by 
Ruden et al10 illustrated that engaging in regular higher-
intensity exercise was associated with increased survival 
for survivors of recurrent brain cancer. However, the cur-
rent trial was not designed with survival as an end point.
Current evidence suggests that screening and treating 
depression in patients with brain cancer should be a primary 
concern for comprehensive care.34 Distress has been classi-
fied as the sixth vital sign, and best-practice cancer care 
should attend to the emotional and psychosocial needs of 
each patient.35 Previous reports indicate that approximately 
50% of neurological cancer survivors suffer with elevated 
distress.36 The 2 participants were included within the larger 
trial particularly because they were distressed; nonetheless, 
in this regard, they are likely very representative of the 
clinical population. The 2 participants both had clinically 
meaningful reductions in depression and total distress, 
measured using the HADS,27,34 after the 12-week exercise 
intervention. These outcomes are in line with evidence that 
exercise reduces depression in depressed individuals37 as 
well as comorbid depression in people with cardiovascular 
disease38 and are unlikely to be attributed to any response 
from medications because these were consistent before and 
during the intervention period.
There was also a large and clinically meaningful categor-
ical shift in satisfaction with life. The scale allows a range of 
5 to 35. Categorical scoring zones have been provided by the 
authors, with each 5-point block (eg, 5-9, 21-25) represent-
ing an increased level of satisfaction with life21; a score of 20 
is classified as the neutral threshold value for this scale.39 At 
baseline, both participants scored on the lower end of the 
scale (11 and 7), but by the conclusion of the exercise 
intervention, participant A increased 3 categorical levels, 
exceeded the neutral threshold, and fell within the “high” 
category. Participant B increased 2 categorical levels from 
“extremely dissatisfied” to “slightly below average” and 
was just 1 point short of reaching the neutral threshold.
Interestingly, the improvements in objective physical 
assessments as well as the improved mental health mea-
sures occurred independently of self-rated physical health 
(PHC from the SF-36), which remained relatively stable for 
participant A and declined considerably for participant B. 
Specifically, for participant A, this may have been partly a 
result of overtraining because she reported increased 
fatigue. Therefore, after 6 weeks participant A was advised 
by the exercise physiologist to reduce her total exercise 
load. The decline in PHC SF-36 score for participant B may 
be explained by the ongoing pharmacotherapy, which 
caused unexpected adverse events such as nosebleeds 
because of blood thinning. This suggests that a general 
measure of health-related quality of life may not be an 
appropriate or clinically meaningful PRO to assess the 
effectiveness of an exercise program in neuro-oncology 
patients, who can have rapidly changing subjective opin-
ions of their health status based on compromised immune 
systems and increased risk of illness or negative prognostic 
feedback from treating clinicians.
This exercise program was supported by the treating 
oncologist of both participants as well as their respective 
family physicians. This process of approval by clinicians 
should be considered as best practice to ensure that there are 
no contraindications to exercise. While recuperating from 
cancer treatment, the introduction or continuation of physi-
cal activity to enhance recovery, reduce toxicity, increase 
physical function, and improve health-related quality of life 
has been recommended by the ACSM8 and further endorsed 
by the ACS.9 The findings reported above, along with new 
and emerging evidence, suggests that exercise is safe and 
beneficial for even the most complex cancer cases, includ-
ing patients with bone metastases40 and those with poor 
prognoses, including pancreatic cancer patients.41
In summary, the outcomes from this report are intended 
to build a level of evidence regarding the benefits of exer-
cise for cancer survivors with brain tumors. However, both 
participants were active at baseline, which may limit the 
generalizability of these findings. Moreover, the duration of 
the intervention was relatively short. Nonetheless, for these 
particular survivors, there were some important and clini-
cally relevant outcomes. If exercise is to be included as 
standard care, it is essential to build on these results and 
determine whether patients with brain cancer continue to 
improve over longer periods of time and whether they are 
able to maintain the adherence levels seen in this study. 
These 2 cases illustrate that, in some cases, exercise is a 
beneficial form of supportive care, improving compro-
mised mental health and enhancing physical capacity for 
brain cancer survivors, regardless of whether they are in 
palliative care or have exceeded the median expectations 
for survival. However, more evidence, including larger 
clinical and controlled trials, is required before these results 
can be broadly translated into clinical practice for all brain 
cancer survivors.
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